AAV Vectors in Gene Therapy Pipeline Experiences Momentum: DelveInsight Estimates a…
<!-- Name:DistributionId Value:8826848 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Comprising
New approach targets norovirus, world’s leading cause of foodborne infection:…
Every year, norovirus causes hundreds of millions of cases of food poisoning -- and the deaths of at least 50,000 children -- yet there exists no real way to control it. The virus has proven…
Thrombocytopenia Pipeline Experiences Momentum: DelveInsight Estimates a Diverse…
<!-- Name:DistributionId Value:8736375 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Psoriatic Arthritis Pipeline Experiences Momentum: DelveInsight Estimates a Diverse…
New York, USA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Psoriatic Arthritis Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the…
Neuroblastoma Pipeline Experiences Momentum: DelveInsight Estimates a Diverse…
New York, USA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Neuroblastoma Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 25+ Companies Working in the Domain…
Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of…
NEWTON, Mass. and GENEVA, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (Acer) and RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief) today…
Hong Kong team comprising student, delivery guys, businessmen make big sacrifices to…
Private coaching, food delivery, jewellery business, administration, and university graduation – the Hong…
Melcor REIT announces new leases comprising over 40,000 sf
EDMONTON, Alberta, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Melcor Real Estate Investment Trust (“the REIT” - TSX: MR.UN) today announced that it has entered into leases with two tenants for…
Scleroderma Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline…
Los Angeles, USA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Scleroderma Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising a Broad Spectrum of Molecular Targets…
Bioasis Announces Allowance of Japanese Patent Application in Japan Relating to xB³™…
NEW HAVEN, Conn., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical…